| Literature DB >> 22402763 |
Simon P B Ovenden1, Jonathan L Nielson, Catherine H Liptrot, Richard H Willis, Dianne M Tapiolas, Anthony D Wright, Cherie A Motti.
Abstract
The methanol extract of an assemblage of Halimeda stuposa and a Dictyota sp., yielded three natural products characteristic of Dictyota sp., and one of Halimeda sp. These included the xenicane diterpene 4-hydroxydictyolactone (1), and the diterpenes dictyol E (2), 8a,11-dihydroxypachydictyol A (3) and indole-3-carboxaldehyde (4). A minor revision of 1 and new spectroscopic data for 1 and 2 are provided, along with associated anti-cancer activities of compounds.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22402763 PMCID: PMC6268996 DOI: 10.3390/molecules17032929
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of the xenicane lactone 4-hydroxydictyolactone (1), the diterpenes dictyol E (2) and 8α,11-dihydroxypachydictyol A (3), and indole-3-carboxaldehyde (4).
Figure 2The possible trans-conformers, based on 1H-NMR coupling constants, viewed along the C=O bond towards C-18, of 4-hydroxydictyolactone (1) as obtained from MM2 calculations [25]; (a) trans-2R,3R,4S,10R; (b) trans-2R,3R,4S,10S; (c) trans-2S,3S,4R,10S and (d) trans-2S,3S,4R,10R. R=(CH2)2CHC(CH3)2.
1H- and 13C-NMR data (300 MHz and 75 MHz, CDCl3) for dictyol E (2).
| No. | 13Cδ (m) | 1Hδ (m, | COSY | gHMBC |
|---|---|---|---|---|
| 1 | 46.0 (d) | 2.60 (1H, q, 9.1) | H2-2, H-5, H2-18 | C-2, C-5, C-6, C-10, C-18 |
| 2 | 33.7 (t) | 2.51 (1H, m ) | H-1, Hb-2 | C-1, C-3, C-4, C-5 |
| 2.22 (1H, dd, 14.8, 7.8) | H-1, Ha-2, H-3 | C-1, C-3, C-4, C-5 | ||
| 3 | 124.2 (d) | 5.34(1H, br s) | Hb-2, H3-17, H-5 | C-1, C-2, C-4, C-5, C-17 |
| 4 | 141.0 (s) | |||
| 5 | 60.4 (d) | 2.37 (1H, m) | H-1, H3-17, H-3, H-6 | C-1, C-3, C-4, C-6, C-10 |
| 6 | 74.7 (d) | 4.20 (1H, dd, 7.8, 2.0) | H-5, H-7 | C-4, C-5, C-7, C-8, |
| 7 | 48.7 (d) | 1.67 (1H, m) | H-6 | C-9, C-11, C-12 |
| 8 | 21.6 (t) | 1.81 (1H, m) | Hb-8, Ha-9 | C-6, C-10, C-19 |
| 1.73 (1H, m,) | Ha-8 | C-7, C-11 | ||
| 9 | 40.6 (t) | 2.69 (1H, ddd, 14.8, 4.6, 2.4) | Hb-9, H2-8 | C-1, C-7, C-8, C-10, C-18 |
| 2.13 (1H, m ) | Ha-9, H2-18 | C-8, C-10, C-18 | ||
| 10 | 152.0 (s) | |||
| 11 | 76.3 (s) | |||
| 12 | 40.9 (t) | 1.74 (2H, t, 8.6) | H2-13 | C-7, C-11, C-13, C-14, C-19 |
| 13 | 23.2 (t) | 2.12 (1H, dd, 14.8, 8.6) | H2-12, Hb-13, H-14 | C-11, C-12, C-14, C-15 |
| 2.02 (1H, dq, 14.8, 6.9) | H2-12, Hb-13, H-14 | C-11, C-12, C-14, C-15 | ||
| 14 | 124.2 (d) | 5.16 (1H, br t, 6.9) | H2-13, H3-20, | C-12, C-13, C-16, C-20 |
| 15 | 132.0 (s) | |||
| 16 | 25.7 (q) | 1.69 (3H, s) | H-14 | C-14, C-15, C-20 |
| 17 | 15.9 (q) | 1.82 (3H, br s) | H-3, H-5 | C-3, C-4, C-5 |
| 18 | 107.4 (t) | 4.78 (1H, br s) | H-1 | C-1, C-5, C-9, C-10 |
| 4.76 (1H, br s) | Hb-9 | C-1, C-5, C-9, C-10 | ||
| 19 | 25.3 (q) | 1.24 (3H, s) | C-7, C-11, C-12 | |
| 20 | 17.5 (q) | 1.62 (3H, br s) | C-14, C-15, C-16 |
Cytotoxicity data [GI50 (µM)] for compounds 1–4 against the human tumour cell lines SF-268, MCF-7, H460, HT-29, the normal human cell line WI38, and the mammalian cell line CHO-K.
| Compound | SF-268 a | MCF-7 b | H460 c | HT-29 d | CHO-K1 e |
|---|---|---|---|---|---|
| 25 | 27 | 20 | 61 | 72 | |
| 16 | 22 | 17 | 46 | 48 | |
| 20 | 38 | 20 | 88 | 103 | |
| NAf | NA | NA | NA | NA |
a SF-268 Central nervous system-glioblastoma cells; b MCF-7 Breast-pleural effusion adenocarcinoma cells; c H460 Lung-large cell carcinoma cells; d HT-29 Colon-recto-sigmoid colon adenocarcinoma cells; e CHO-K1 Sub-clone of Chinese hamster ovary cells; f NA = not active.